Proposed registration of dirlotapide in the product Slentrol

This consultation closed on 10 September 2013.
Consultation period: 
13 August 2013 to 10 September 2013

The APVMA is considering an application for the registration of Slentrol. The product is to be registered as an aid in the management of overweight and obesity in adult dogs.

We invite comment from 13 August 2013 to 10 September 2013 on whether the application for registration should be granted.

The APVMA is able to consider comments relating to the legislative grounds for registration, including:

  • occupational health and safety
  • safety and first aid
  • chemistry and manufacture
  • residues
  • environmental fate and toxicity
  • trade
  • efficacy.

For more information, see page 12 of Gazette No. 16 - 13 August 2013.

Please send your written submission by email, post or fax to:

Veterinary Medicines Program
Australian Pesticides and Veterinary Medicines Authority
PO Box 6182
Kingston ACT 2604

Email: vetmedicines@apvma.gov.au
Fax: +61 2 6210 4721

For enquiries, please call +61 2 6210 4701.

To protect your privacy, please do not include contact information in your feedback. If you would like a response, please contact us.